Cargando…

Tolerability and efficacy of the intestinal phosphate binder Lantharenol(® )in cats

BACKGROUND: Tolerability and efficacy of the intestinal phosphate binder Lantharenol(® )(lanthanum carbonate octahydrate) were tested in two prospective, randomized and negative controlled laboratory studies with healthy adult cats fed commercial maintenance diets non-restricted in phosphorus. In th...

Descripción completa

Detalles Bibliográficos
Autores principales:	Schmidt, Bernard H, Dribusch, Ute, Delport, Peet C, Gropp, Jürgen M, van der Staay, F Josef
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2012
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3395877/ https://www.ncbi.nlm.nih.gov/pubmed/22305206 http://dx.doi.org/10.1186/1746-6148-8-14

Ejemplares similares

Assessment of the application for renewal of authorisation of Lantharenol(®) (lanthanum carbonate octahydrate) for cats
por: Bampidis, Vasileios, et al.
Publicado: (2019)

Efficacy, acceptability and tolerability of the new oral phosphate binder Lenziaren® in healthy cats fed a standard diet
por: King, Jonathan N, et al.
Publicado: (2014)

Preventive efficacy of Frontline(®) Combo and Certifect(®) against Dipylidium caninum infestation of cats and dogs using a natural flea (Ctenocephalides felis) infestation model
por: Beugnet, Frederic, et al.
Publicado: (2013)

Iron-based phosphate binders: do they offer advantages over currently available phosphate binders?
por: Negri, Armando Luis, et al.
Publicado: (2015)

Pharmacology of the Phosphate Binder, Lanthanum Carbonate
por: Damment, Stephen JP
Publicado: (2011)

Pentose Phosphate Pathway Function Affects Tolerance to the G-Quadruplex Binder TMPyP4
por: Andrew, Elizabeth J., et al.
Publicado: (2013)

Effectiveness and cost-efficiency of phosphate binders in hemodialysis
por: Fröschl, Barbara, et al.
Publicado: (2009)

Preparation of acid aluminum phosphate solutions for metakaolin phosphate geopolymer binder
por: Yankwa Djobo, Jean Noël, et al.
Publicado: (2021)

A phase III study of the efficacy and safety of a novel iron-based phosphate binder in dialysis patients
por: Floege, Jürgen, et al.
Publicado: (2014)

Analysis of serum phosphate control and phosphate binder utilization in incident hemodialysis patients
por: Farrand, Kimberly F, et al.
Publicado: (2014)

Managing Phosphate Burden in Patients Receiving Dialysis: Beyond Phosphate Binders and Diet
por: Kalantar-Zadeh, Kamyar, et al.
Publicado: (2023)

The demise of calcium-based phosphate binders—is this appropriate for children?
por: Rees, Lesley, et al.
Publicado: (2014)

Do we need new phosphate binders in dialysis?
por: Cozzolino, Mario, et al.
Publicado: (2020)

Phosphate binders in dialysis: better satisfied than sorry
por: Cozzolino, Mario, et al.
Publicado: (2021)

Effect of Tenapanor on Phosphate Binder Pill Burden in Hemodialysis Patients
por: Akizawa, Tadao, et al.
Publicado: (2021)

Long-term effects of the iron-based phosphate binder, sucroferric oxyhydroxide, in dialysis patients
por: Floege, Jürgen, et al.
Publicado: (2015)

Efficacy of Lanthanum Carbonate and Sevelamer Carbonate as Phosphate Binders in Chronic Kidney Disease—A Comparative Clinical Study
por: Nain, Parminder, et al.
Publicado: (2023)

Ferric Citrate Hydrate as a Phosphate Binder and Risk of Aluminum Toxicity
por: Gupta, Ajay
Publicado: (2014)

Prescribing pattern of medicines in chronic kidney disease with emphasis on phosphate binders
por: Bajait, Chaitali S, et al.
Publicado: (2014)

Phosphate binders for the treatment of chronic kidney disease: role of iron oxyhydroxide
por: Cernaro, Valeria, et al.
Publicado: (2016)

Research on preparation of phosphate-modified animal glue binder for foundry use
por: Wang, Tian-Shu, et al.
Publicado: (2018)

The role of kidney transplantation and phosphate binder use in vitamin K status
por: Jansz, Thijs T., et al.
Publicado: (2018)

Interventional study to improve adherence to phosphate binder treatment in dialysis patients
por: Hjemås, Bodil Jahren, et al.
Publicado: (2019)

Randomized Study of Tenapanor Added to Phosphate Binders for Patients With Refractory Hyperphosphatemia
por: Nitta, Kosaku, et al.
Publicado: (2023)

Influence of pH and phosphate concentration on the phosphate binding capacity of five contemporary binders. An in vitro study
por: Schumacher, Stefan P, et al.
Publicado: (2018)

Evaluation of calcium acetate/magnesium carbonate as a phosphate binder compared with sevelamer hydrochloride in haemodialysis patients: a controlled randomized study (CALMAG study) assessing efficacy and tolerability
por: de Francisco, Angel L.M., et al.
Publicado: (2010)

Do oral aluminium phosphate binders cause accumulation of aluminium to toxic levels?
por: Pepper, Ruth, et al.
Publicado: (2011)

Phosphate binders affect vitamin K concentration by undesired binding, an in vitro study
por: Neradova, A., et al.
Publicado: (2017)

Provider Attitudes and Support of Patients’ Autonomy for Phosphate Binder Medication Adherence in ESRD
por: Umeukeje, Ebele M, et al.
Publicado: (2019)

Intact FGF23 predicts serum phosphate improvement after combined nicotinamide and phosphate binder treatment in hemodialysis patients
por: Egli-Spichtig, Daniela, et al.
Publicado: (2023)

High Phosphate-Binding Capacity of Oxylanthanum Carbonate with a Low Medication Volume: Comparison with Commercially Available Phosphate Binders
por: Sprague, Stuart M., et al.
Publicado: (2023)

Potentially modifiable factors associated with non-adherence to phosphate binder use in patients on hemodialysis
por: Martins, Maria Tereza Silveira, et al.
Publicado: (2013)

Calcium-based phosphate binder use is associated with lower risk of osteoporosis in hemodialysis patients
por: Hashimoto, Hiroko, et al.
Publicado: (2021)

Effects of education on low-phosphate diet and phosphate binder intake to control serum phosphate among maintenance hemodialysis patients: A randomized controlled trial
por: Lim, Eunsoo, et al.
Publicado: (2018)

Behavioral models in psychopathology: epistemic and semantic considerations
por: Maximino, Caio, et al.
Publicado: (2019)

Do aluminium-based phosphate binders continue to have a role in contemporary nephrology practice?
por: Mudge, David W, et al.
Publicado: (2011)

Effect of a magnesium-based phosphate binder on medial calcification in a rat model of uremia
por: De Schutter, Tineke M, et al.
Publicado: (2013)

Preclinical and Healthy Volunteer Studies of Potential Drug–Drug Interactions Between Tenapanor and Phosphate Binders
por: Johansson, Susanne, et al.
Publicado: (2016)

One-Year Historical Cohort Study of the Phosphate Binder Sucroferric Oxyhydroxide in Patients on Maintenance Hemodialysis
por: Kendrick, Jessica, et al.
Publicado: (2019)

Effect of the P/Al Molar Ratio and Heating Rate on the Composi-Tion of Alumino-Phosphate Binders
por: Tricot, Grégory, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_pld63kci89buo8djii4e74dj8f